Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Huixin Bio logo — Pioneering advances in liquid biopsy diagnostics with ground...

Huixin Bio

Pioneering advances in liquid biopsy diagnostics with groundbreaking biomedical technologies and an innovation-driven exosome purification system.

Founded 2017 Seed Biopharma, Biotechnology +1

General Information

Company Name Huixin Bio
Founded Year 2017
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Seed
Social

Get notified when Huixin Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Huixin Bio

Huixin Bio is a pioneering startup in the field of liquid biopsy diagnostics, aiming to revolutionize the industry with its cutting-edge biomedical technologies and an innovation-driven exosome purification system. Founded in 2017, the company is dedicated to the research and development of world-leading biomedical technologies and products, with a particular focus on automatic exosome purification system. Its commitment to innovation and advancement has attracted the attention of investors, as evidenced by the Seed Round investment received on 19 January 2023 from South China VC. Operating within the Biopharma, Biotechnology, and Pharmaceutical industries, Huixin Bio is poised to make significant contributions to the rapidly evolving field of liquid biopsy diagnostics.

Taxonomy: liquid biopsy diagnostics, biomedical technologies, exosome purification system, biomedical products, innovation-driven, biotech startup, biomedical innovation, diagnostic technology, biomedical research, biotech industry, medical diagnostics, biomedical engineering, innovative healthcare, biomedical devices

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
19 Jan 2023

Huixin Bio Alternatives & Competitors

Huixin Bio vs
SYSTAAQ Diagnostic Product Inc
SYSTAAQ Diagnostic Product Inc United States

Provides a broad portfolio of Molecular Products. We design, develop and manufacture Real Time PCR a...

5 employees
Biotechnology, Health Care
Huixin Bio vs
BioM Biotech Cluster Development GmbH
BioM Biotech Cluster Development GmbH

Management organisation for the Bavarian biotechnology - We accelerate medical innovation

28 employees
Biotechnology
Huixin Bio vs
Diagonal Bio
Diagonal Bio Sweden

Pathogen diagnostics with unprecedented speed, accuracy and ease

10 employees
Biotechnology, Health Care

FAQ About Huixin Bio

Pioneering advances in liquid biopsy diagnostics with groundbreaking biomedical technologies and an innovation-driven exosome purification system.
Huixin Bio was founded in 2017.
Huixin Bio operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Huixin Bio has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Huixin Bio include SYSTAAQ Diagnostic Product Inc, BioM Biotech Cluster Development GmbH, Diagonal Bio, Multiwave Technologies AG, Calico Biolabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Huixin Bio and SYSTAAQ Diagnostic Product Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Huixin Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy